Validation of Muscle Strength Testing for Pectoralis Major

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hsin-Min Lee, National Science Council, Taiwan
ClinicalTrials.gov Identifier:
NCT01636115
First received: July 5, 2012
Last updated: December 5, 2012
Last verified: December 2012
  Purpose

This study wants to understand which direction of shoulder movement and what posture of shoulder are best for the procedure of muscle strength testing of the muscle pectoralis major(PM). We will use muscle activity signals (sEMG) and force measurement to analyze the contribution of two parts of PM in three different contraction direction with three different shoulder postures.


Condition
Pectoralis Major
Muscle Strength
Surface EMG
Force Measurement

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: Validation of Muscle Strength Testing for Pectoralis Major

Further study details as provided by National Science Council, Taiwan:

Primary Outcome Measures:
  • sEMG [ Time Frame: 6/1/2012 ] [ Designated as safety issue: Yes ]
    Surface EMG signal were collected.


Enrollment: 24
Study Start Date: May 2012
Study Completion Date: November 2012
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   17 Years to 30 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Students in University.

Criteria

Inclusion Criteria:

  • Young male subjects which could expose the area of anterior chest to paste the sEMG electrodes

Exclusion Criteria:

  • Injury and uncomforted one week before the test
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01636115

Locations
Taiwan
I-Shou university
Kaohsiung, Taiwan
Sponsors and Collaborators
National Science Council, Taiwan
  More Information

No publications provided

Responsible Party: Hsin-Min Lee, Associate Professor, National Science Council, Taiwan
ClinicalTrials.gov Identifier: NCT01636115     History of Changes
Other Study ID Numbers: ISU-IRB-101-001
Study First Received: July 5, 2012
Last Updated: December 5, 2012
Health Authority: Taiwan: Institutional Review Board

ClinicalTrials.gov processed this record on August 28, 2014